2026· International Journal of Computational Mathematical Ideas· 0 citations
TL;DR
The results argue that in medicine the safety of an agentic system is engineered at the level of the loop, through verification, risk-weighted escalation, and clinician oversight, and can be designed and reasoned about rather than left to chance.
Abstract
Agentic artificial intelligence, in which a model reasons, calls tools, and acts in a closed loop rather than emitting a single prediction, is arriving in medicine, where the tolerance for confident error is close to zero. This paper takes a design stance on healthcare agentic AI: rather than propose a new model, it asks how to build a clinical agentic system so that its autonomy is bounded by verification and human oversight. We distil six design requirements from the clinical AI literature, covering harm minimisation, human oversight, calibrated uncertainty, verification and provenance, equity, and interpretability. We give a reference architecture in which a reasoning agent is wrapped by a verification gate and a clinician escalation path, and we formalise that gate. We prove two guarantees: escalation is monotone in safety, so widening it never increases expected harm, and a risk-weighted gate minimises expected harm for any fixed amount of clinician effort. We validate the design with a fully reproducible simulation of an agentic clinical triage loop. The escalation gate trades autonomy for safety along a smooth curve, halving expected harm as oversight rises; layering an independent verifier and human review cuts the unsafe-action rate from 0.230 with the agent alone to 0.077; and risk-weighted escalation attains lower harm than confidence-only escalation at every clinician budget, exactly as the theory predicts. The results argue that in medicine the safety of an agentic system is engineered at the level of the loop, through verification, risk-weighted escalation, and clinician oversight, and can be designed and reasoned about rather than left to chance.
ClinicalAgentOps is proposed, a framework that relocates governance from the artifact into the agent’s execution path and contributes an explicit argument from the premises of design-time assurance to the necessity of inpath control.
Kamal Singh Bisht, R. Kumar· International Journal For Mu...· 0 citations
It is argued that each of the four challenges facing responsible development is addressed by a clinical testing harness: a structured evaluation environment comprising scenario libraries built from clinical edge cases, full-trajectory observability, explicit escalation testing, and staged evidence thresholds tied to sc...
E. Waisberg, Joseph W. Guarnieri· Annals of Biomedical Enginee...· 0 citations
Agentic artificial intelligence (AI), comprising autonomous, goal-oriented systems capable of reasoning, planning, and coordinating multi-step clinical workflows under clinician oversight, is emerging as a transformative paradigm in modern healthcare. This study presents a systematic review of its conceptual foundation...
Healthcare systems are increasingly data-rich but remain fragmented, reactive, and difficult to coordinate across institutions, devices, and clinical workflows. Healthcare 5.0 addresses these limitations through human-centricity, resilience, and symbiotic human-artificial intelligence (AI) collaboration. This survey po...
T. Gadekallu, Thien Huynh-The, A. Chehri et al.· IEEE Internet of Things Jour...· 0 citations
Analysis of six areas of artificial intelligence in healthcare concludes that a workable framework must combine the principles of medical negligence law with data protection, consumer protection and sectoral safety requirements, together with governance mechanisms for artificial intelligence such as human oversight, au...
Ashish Kumar Kureel, B. Yadav· International Journal of Law...· 0 citations
A fully on-premise clinical agent that couples local operational control with a multi-perspective reliability framework to support selective autonomy is developed and evaluated, supporting a practical framework for institutionally governed clinical agents.
Li Zhang, G. Wölflein, Dyke Ferber et al.· Nature Medicine· 4 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.